Top

Published in:

01-05-2013

TAVI 2012: state of the art

Authors: Jochen Reinöhl, Constantin von zur Mühlen, Martin Moser, Stefan Sorg, Christoph Bode, Manfred Zehender

Published in: Journal of Thrombosis and Thrombolysis | Issue 4/2013

Abstract

The development of “transcatheter aortic valve implantation (TAVI)” is changing the field of cardiovascular medicine rapidly. The basic principle of TAVI is the percutaneous implantation of a bioprosthesis mounted in a metal frame. The prosthesis, which is attached to the tip of the catheter, is positioned in the native aortic valve and expanded. The first successful implantation was made by Alain Cribier in 2002. Several smaller mono- and multicenter studies later confirmed the technical feasibility of this procedure. Its true value as an important, therapeutic alternative to open heart surgery in inoperable and high-risk patients is now confirmed in large multicenter registries and by the prospective, randomized PARTNER trial. Decisive for the future acceptance of the procedure and for a possible expansion of the indication spectrum will be (1) continuous further development of the implantation technique and the prosthesis design, (2) reduction of TAVI-associated complications, (3) confirmation of the initial positive long-term results and (4) confirmation of the promising results in the treatment of surgical prosthesis dysfunctions and of patients with low to intermediate risk.

Webb JG, Altwegg L, Boone RH, Cheung A, Ye J, Lichtenstein S, Lee M, Masson JB, Thompson C, Moss R, Carere R, Munt B, Nietlispach F, Humphries K (2009) Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 119:3009–3016PubMed

Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A (2007) Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the european society of cardiology. Eur Heart J 28:230–268PubMed

Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Page RL, Riegel B (2006) Acc/aha 2006 guidelines for the management of patients with valvular heart disease: a report of the american college of cardiology/american heart association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): developed in collaboration with the society of cardiovascular anesthesiologists: endorsed by the society for cardiovascular angiography and interventions and the society of thoracic surgeons. Circulation 114:e84–e231PubMed

Kolh P, Kerzmann A, Lahaye L, Gerard P, Limet R (2001) Cardiac surgery in octogenarians; peri-operative outcome and long-term results. Eur Heart J 22:1235–1243PubMed

Charlson E, Legedza AT, Hamel MB (2006) Decision-making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis 15:312–321PubMed

Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, Gohlke-Barwolf C, Boersma E, Ravaud P, Vahanian A (2005) Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 26:2714–2720PubMed

Moulopoulos SD, Anthopoulos L, Stamatelopoulos S, Stefadouros M (1971) Catheter-mounted aortic valves. Ann Thorac Surg 11:423–430PubMed

Paniagua D, Condado JA, Besso J, Velez M, Burger B, Bibbo S, Cedeno D, Acquatella H, Mejia C, Induni E, Fish RD (2005) First human case of retrograde transcatheter implantation of an aortic valve prosthesis. Tex Heart Inst J 32:393–398PubMed

Davies H (1965) Catheter mounted valve for temporary relief of aortic insufficiency. Lancet 1:250

10.

Andersen HR, Knudsen LL, Hasenkam JM (1992) Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 13:704–708PubMed

11.

Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D, Acar P, Le Bidois J, Sidi D, Kachaner J (2000) Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 356:1403–1405PubMed

12.

Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106:3006–3008PubMed

13.

Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607PubMed

14.

Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G, Iung B, Donzeau-Gouge P, Tribouilloy C, Debrux JL, Pavie A, Gueret P (2011) Transcatheter aortic valve implantation: early results of the FRANCE (French Aortic National CoreValve and Edwards) registry. Eur Heart J 32:191–197PubMed

15.

Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O (2010) Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122:62–69PubMed

16.

Baumgartner H (2006) Hemodynamic assessment of aortic stenosis: are there still lessons to learn? J Am Coll Cardiol 47:138–140PubMed

17.

Smid M, Ferda J, Baxa J, Cech J, Hajek T, Kreuzberg B, Rokyta R (2010) Aortic annulus and ascending aorta: comparison of preoperative and periooperative measurement in patients with aortic stenosis. Eur J Radiol 74:152–155PubMed

18.

Ng AC, Delgado V, van der Kley F, Shanks M, van de Veire NR, Bertini M, Nucifora G, van Bommel RJ, Tops LF, de Weger A, Tavilla G, de Roos A, Kroft LJ, Leung DY, Schuijf J, Schalij MJ, Bax JJ (2010) Comparison of aortic root dimensions and geometries before and after transcatheter aortic valve implantation by 2- and 3-dimensional transesophageal echocardiography and multislice computed tomography. Circ Cardiovasc Imaging 3:94–102PubMed

19.

Blanke P, Siepe M, Reinohl J, Zehender M, Beyersdorf F, Schlensak C, Langer M, Pache G (2010) Assessment of aortic annulus dimensions for Edwards SAPIEN Transapical Heart Valve implantation by computed tomography: calculating average diameter using a virtual ring method. Eur J Cardio-Thorac Surg 38:750–758

20.

Vahanian A, Alfieri OR, Al-Attar N, Antunes MJ, Bax J, Cormier B, Cribier A, De Jaegere P, Fournial G, Kappetein AP, Kovac J, Ludgate S, Maisano F, Moat N, Mohr FW, Nataf P, Pierard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout B, von Segesser LK, Walther T (2008) Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg 34:1–8PubMed

21.

Delgado V, Ng AC, Shanks M, van der Kley F, Schuijf JD, van de Veire NR, Kroft L, de Roos A, Schalij MJ, Bax JJ (2010) Transcatheter aortic valve implantation: role of multimodality cardiac imaging. Expert Rev Cardiovasc Ther 8:113–123PubMed

22.

Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, Buller CE, Pasupati S, Lichtenstein S (2006) Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113:842–850PubMed

23.

Kaleschke G, Seifarth H, Kerckhoff G, Reinecke H, Baumgartner H (2010) Imaging decision-making for transfemoral or transapical approach of transcatheter aortic valve implantation. EuroIntervention 6(Suppl G):G20–G27PubMed

24.

Masson JB, Kovac J, Schuler G, Ye J, Cheung A, Kapadia S, Tuzcu ME, Kodali S, Leon MB, Webb JG (2009) Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv 2:811–820PubMed

25.

Lichtenstein SV, Cheung A, Ye J, Thompson CR, Carere RG, Pasupati S, Webb JG (2006) Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 114:591–596PubMed

26.

Mukherjee C, Walther T, Borger MA, Kempfert J, Schuler G, Mohr FW, Ender J (2009) Awake transapical aortic valve implantation using thoracic epidural anesthesia. Ann Thorac Surg 88:992–994PubMed

27.

Petronio AS, De Carlo M, Bedogni F, Marzocchi A, Klugmann S, Maisano F, Ramondo A, Ussia GP, Ettori F, Poli A, Brambilla N, Saia F, De Marco F, Colombo A (2010) Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv 3:359–366PubMed

28.

Bauernschmitt R, Schreiber C, Bleiziffer S, Ruge H, Mazzitelli D, Hutter A, Tassani P, Lange R (2009) Transcatheter aortic valve implantation through the ascending aorta: an alternative option for no-access patients. Heart Surg Forum 12:E63–E64PubMed

29.

Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198PubMed

30.

Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB (2012) Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 366:1686–1695PubMed

31.

Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW (2008) Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 4:242–249PubMed

32.

Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP (2011) Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123:299–308PubMed

33.

Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richardt G, Figulla HR, Senges J (2011) Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 32:198–204PubMed

34.

Moat NE, Ludman P, de Belder MA, Bridgewater B, Cunningham AD, Young CP, Thomas M, Kovac J, Spyt T, MacCarthy PA, Wendler O, Hildick-Smith D, Davies SW, Trivedi U, Blackman DJ, Levy RD, Brecker SJ, Baumbach A, Daniel T, Gray H, Mullen MJ (2011) Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 58:2130–2138PubMed

35.

Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochelliere R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E (2010) Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter canadian experience. J Am Coll Cardiol 55:1080–1090PubMed

36.

Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, Bash A, Nusimovici D, Litzler PY, Bessou JP, Leon MB (2004) Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 43:698–703PubMed

37.

Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, Sinhal A, Carere RG, Munt B, Ricci D, Ye J, Cheung A, Lichtenstein SV (2007) Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 116:755–763PubMed

38.

Walther T, Simon P, Dewey T, Wimmer-Greinecker G, Falk V, Kasimir MT, Doss M, Borger MA, Schuler G, Glogar D, Fehske W, Wolner E, Mohr FW, Mack M (2007) Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 116:I240–I245PubMed

39.

Svensson LG, Dewey T, Kapadia S, Roselli EE, Stewart A, Williams M, Anderson WN, Brown D, Leon M, Lytle B, Moses J, Mack M, Tuzcu M, Smith C (2008) United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg 86:46–54; discussion 54–45PubMed

40.

Walther T, Kasimir MT, Doss M, Schuler G, Simon P, Schachinger V, Mohr FW, Wimmer-Greinecker G (2011) One-year interim follow-up results of the TRAVERCE trial: the initial feasibility study for trans-apical aortic-valve implantation. Eur J Cardiothorac Surg 39:532–537PubMed

41.

Rodes-Cabau J, Dumont E, De LaRochelliere R, Doyle D, Lemieux J, Bergeron S, Clavel MA, Villeneuve J, Raby K, Bertrand OF, Pibarot P (2008) Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. Am J Cardiol 102:1240–1246PubMed

42.

Lefevre T, Kappetein AP, Wolner E, Nataf P, Thomas M, Schachinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Serruys P, Wimmer-Greinecker G (2011) One year follow-up of the multi-centre european partner transcatheter heart valve study. Eur Heart J 32:148–157PubMed

43.

Grube E, Laborde JC, Zickmann B, Gerckens U, Felderhoff T, Sauren B, Bootsveld A, Buellesfeld L, Iversen S (2005) First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv 66:465–469PubMed

44.

Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW (2006) Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg First-in-Man study. Circulation 114:1616–1624PubMed

45.

Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50:69–76PubMed

46.

Bosmans JM, Kefer J, De Bruyne B, Herijgers P, Dubois C, Legrand V, Verheye S, Rodrigus I (2011) Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national Registry. Interact Cardiovasc Thorac Surg 12:762–767PubMed

47.

Clavel MA, Webb JG, Rodes-Cabau J, Masson JB, Dumont E, De Larochelliere R, Doyle D, Bergeron S, Baumgartner H, Burwash IG, Dumesnil JG, Mundigler G, Moss R, Kempny A, Bagur R, Bergler-Klein J, Gurvitch R, Mathieu P, Pibarot P (2010) Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation 122:1928–1936PubMed

48.

Clavel MA, Webb JG, Pibarot P, Altwegg L, Dumont E, Thompson C, De Larochelliere R, Doyle D, Masson JB, Bergeron S, Bertrand OF, Rodes-Cabau J (2009) Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol 53:1883–1891PubMed

49.

Bauer F, Eltchaninoff H, Tron C, Lesault PF, Agatiello C, Nercolini D, Derumeaux G, Cribier A (2004) Acute improvement in global and regional left ventricular systolic function after percutaneous heart valve implantation in patients with symptomatic aortic stenosis. Circulation 110:1473–1476PubMed

50.

Bagur R, Rodes-Cabau J, Dumont E, Larochelliere RD, Doyle D, Bertrand OF, Cote M, Poirier P, Pibarot P (2011) Exercise capacity in patients with severe symptomatic aortic stenosis before and six months after transcatheter aortic valve implantation. Am J Cardiol 108:258–264PubMed

51.

Reynolds MR, Magnuson EA, Lei Y, Leon MB, Smith CR, Svensson LG, Webb JG, Babaliaros VC, Bowers BS, Fearon WF, Herrmann HC, Kapadia S, Kodali SK, Makkar RR, Pichard AD, Cohen DJ (2011) Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation 124:1964–1972PubMed

52.

Goncalves A, Marcos-Alberca P, Almeria C, Feltes G, Hernandez-Antolin RA, Rodriguez E, Rodrigo JL, Cobiella J, Maroto L, Cardoso JC, Macaya C, Zamorano JL (2011) Quality of life improvement at midterm follow-up after transcatheter aortic valve implantation. Int J Cardiol. doi: 10.1016/j.ijcard.2011.05.050

53.

Bagur R, Rodes-Cabau J, Dumont E, De Larochelliere R, Doyle D, Pibarot P, Cote M, Clavel MA, Villeneuve J, Gutierrez M, Poirier P, Bertrand OF (2011) Performance-based functional assessment of patients undergoing transcatheter aortic valve implantation. Am Heart J 161:726–734PubMed

54.

Ussia GP, Mule M, Barbanti M, Cammalleri V, Scarabelli M, Imme S, Capodanno D, Ciriminna S, Tamburino C (2009) Quality of life assessment after percutaneous aortic valve implantation. Eur Heart J 30:1790–1796PubMed

55.

Gotzmann M, Pljakic A, Bojara W, Lindstaedt M, Ewers A, Germing A, Mugge A (2011) Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response. Am Heart J 162(238–245):e231

56.

Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H, Eggebrecht H, Rubino P, Colombo A, Lange R, Schwarz RR, Wendler O (2011) One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 124:425–433PubMed

57.

Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carrie D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R, Delpine S, Souteyrand G, Favereau X, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel JP, Bourlon F, Bertrand B, Van Belle E, Laskar M (2012) Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 366:1705–1715PubMed

58.

Nuis RJ, Van Mieghem NM, Tzikas A, Piazza N, Otten AM, Cheng J, van Domburg RT, Betjes M, Serruys PW, de Jaegere PP (2011) Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv 77:881–889PubMed

59.

Sinning JM, Ghanem A, Steinhauser H, Adenauer V, Hammerstingl C, Nickenig G, Werner N (2010) Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 3:1141–1149PubMed

60.

Wenaweser P, Pilgrim T, Roth N, Kadner A, Stortecky S, Kalesan B, Meuli F, Bullesfeld L, Khattab AA, Huber C, Eberle B, Erdos G, Meier B, Juni P, Carrel T, Windecker S (2011) Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J 161:1114–1124PubMed

61.

Dewey TM, Brown DL, Herbert MA, Culica D, Smith CR, Leon MB, Svensson LG, Tuzcu M, Webb JG, Cribier A, Mack MJ (2010) Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg 89:758–767; discussion 767PubMed

62.

Abdel-Wahab M, Zahn R, Horack M, Gerckens U, Schuler G, Sievert H, Eggebrecht H, Senges J, Richardt G (2011) Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the german transcatheter aortic valve interventions registry. Heart 97:899–906PubMed

63.

Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC, Bavaria JE, Kodali S, Brown DL, Bowers B, Dewey TM, Svensson LG, Tuzcu M, Moses JW, Williams MR, Siegel RJ, Akin JJ, Anderson WN, Pocock S, Smith CR, Leon MB (2012) Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 366:1696–1704PubMed

64.

Buellesfeld L, Gerckens U, Schuler G, Bonan R, Kovac J, Serruys PW, Labinaz M, den Heijer P, Mullen M, Tymchak W, Windecker S, Mueller R, Grube E (2011) 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am Coll Cardiol 57:1650–1657PubMed

65.

Gurvitch R, Wood DA, Tay EL, Leipsic J, Ye J, Lichtenstein SV, Thompson CR, Carere RG, Wijesinghe N, Nietlispach F, Boone RH, Lauck S, Cheung A, Webb JG (2010) Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation 122:1319–1327PubMed

66.

Rodes-Cabau J, Webb J, Cheung A, Ye J, Dumont E, Chris F, Osten M, Natarajan M, Velianou JL, Martucci G, DeVarennes B, Thompson CR, Chisholm R, Peterson M, Lichtenstein S, Toggweiler S, Doyle D, DeLarochelli√®re R, Dumesnil J, Teoh K, Chu V, Cheema A, Wood D, Pibarot P, Horlick E (2012) Long-term outcomes following transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the canadian multicenter experience. J Am Coll Cardiol 59:E10–E10

67.

Alli OO, Booker JD, Lennon RJ, Greason KL, Rihal CS, Holmes DR Jr (2012) Transcatheter aortic valve implantation: assessing the learning curve. JACC Cardiovasc Interv 5:72–79PubMed

68.

Nuis RJ, van Mieghem NM, van der Boon RM, van Geuns RJ, Schultz CJ, Oei FB, Galema TW, Raap GB, Koudstaal PJ, Geleijnse ML, Kappetein AP, Serruys PW, de Jaegere PP (2011) Effect of experience on results of transcatheter aortic valve implantation using a medtronic CoreValve system. Am J Cardiol 107:1824–1829PubMed

69.

Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW (2011) Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the valve academic research consortium. Eur Heart J 32:205–217PubMed

70.

Eggebrecht H, Schmermund A, Voigtlander T, Kahlert P, Erbel R, Mehta RH (2012) Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 8:129–138PubMed

71.

Kahlert P, Knipp SC, Schlamann M, Thielmann M, Al-Rashid F, Weber M, Johansson U, Wendt D, Jakob HG, Forsting M, Sack S, Erbel R, Eggebrecht H (2010) Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 121:870–878PubMed

72.

Ghanem A, Muller A, Nahle CP, Kocurek J, Werner N, Hammerstingl C, Schild HH, Schwab JO, Mellert F, Fimmers R, Nickenig G, Thomas D (2010) Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol 55:1427–1432PubMed

73.

Rodes-Cabau J, Dumont E, Boone RH, Larose E, Bagur R, Gurvitch R, Bedard F, Doyle D, De Larochelliere R, Jayasuria C, Villeneuve J, Marrero A, Cote M, Pibarot P, Webb JG (2011) Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol 57:18–28PubMed

74.

Szeto WY, Augoustides JG, Desai ND, Moeller P, McGarvey ML, Walsh E, Bannan A, Herrmann HC, Bavaria JE (2011) Cerebral embolic exposure during transfemoral and transapical transcatheter aortic valve replacement. J Card Surg 26:348–354PubMed

75.

Nuis RJ, Piazza N, Van Mieghem NM, Otten AM, Tzikas A, Schultz CJ, van der Boon R, van Geuns RJ, van Domburg RT, Koudstaal PJ, Kappetein AP, Serruys PW, de Jaegere PP (2011) In-hospital complications after transcatheter aortic valve implantation revisited according to the valve academic research consortium definitions. Catheter Cardiovasc Interv 78:457–467PubMed

76.

Nietlispach F, Wijesinghe N, Gurvitch R, Tay E, Carpenter JP, Burns C, Wood DA, Webb JG (2010) An embolic deflection device for aortic valve interventions. JACC Cardiovasc Interv 3:1133–1138PubMed

77.

Ussia GP, Scarabelli M, Mule M, Barbanti M, Sarkar K, Cammalleri V, Imme S, Aruta P, Pistritto AM, Gulino S, Deste W, Capodanno D, Tamburino C (2011) Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. Am J Cardiol 108:1772–1776PubMed

78.

Hayashida K, Lefevre T, Chevalier B, Hovasse T, Romano M, Garot P, Mylotte D, Uribe J, Farge A, Donzeau-Gouge P, Bouvier E, Cormier B, Morice MC (2011) Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv 4:851–858PubMed

79.

Godino C, Maisano F, Montorfano M, Latib A, Chieffo A, Michev I, Al-Lamee R, Bande M, Mussardo M, Arioli F, Ielasi A, Cioni M, Taramasso M, Arendar I, Grimaldi A, Spagnolo P, Zangrillo A, La Canna G, Alfieri O, Colombo A (2010) Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience. JACC Cardiovasc Interv 3:1110–1121PubMed

80.

Moynagh AM, Scott DJ, Baumbach A, Khavandi A, Brecker SJ, Laborde JC, Brown S, Chowdhary S, Saravanan D, Crean PA, Teehan S, Hildick-Smith D, Trivedi U, Khogali SS, Bhabra MS, Roberts DH, Morgan KP, Blackman DJ (2011) CoreValve transcatheter aortic valve implantation via the subclavian artery: comparison with the transfemoral approach. J Am Coll Cardiol 57:634–635PubMed

82.

Kahlert P, Al-Rashid F, Weber M, Wendt D, Heine T, Kottenberg E, Thielmann M, Kuhl H, Peters J, Jakob HG, Sack S, Erbel R, Eggebrecht H (2009) Vascular access site complications after percutaneous transfemoral aortic valve implantation. Herz. 34:398–408PubMed

82.

Cockburn J, de Belder A, Brooks M, Hutchinson N, Hill A, Trivedi U, Hildick-Smith D (2012) Large calibre arterial access device closure for percutaneous aortic valve interventions: use of the Prostar system in 118 cases. Catheter Cardiovasc Interv 79:143–149PubMed

83.

Van Mieghem NM, Nuis RJ, Piazza N, Apostolos T, Ligthart J, Schultz C, de Jaegere PP, Serruys PW (2010) Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience. EuroIntervention 5:673–679PubMed

84.

Sharp AS, Michev I, Maisano F, Taramasso M, Godino C, Latib A, Denti P, Dorigo E, Giacomini A, Iaci G, Manca M, Ielasi A, Montorfano M, Alfieri O, Colombo A (2010) A new technique for vascular access management in transcatheter aortic valve implantation. Catheter Cardiovasc Interv 75:784–793PubMed

85.

Saia F, Bordoni B, Marrozzini C, Ciuca C, Moretti C, Branzi A, Marzocchi A (2011) Incidence, prognostic value and management of vascular complications with transfemoral transcatheter aortic valve implantation. Future Cardiol 7:321–331PubMed

86.

Sinhal A, Altwegg L, Pasupati S, Humphries KH, Allard M, Martin P, Cheung A, Ye J, Kerr C, Lichtenstein SV, Webb JG (2008) Atrioventricular block after transcatheter balloon expandable aortic valve implantation. JACC Cardiovasc Interv 1:305–309PubMed

87.

Gutierrez M, Rodes-Cabau J, Bagur R, Doyle D, DeLarochelliere R, Bergeron S, Lemieux J, Villeneuve J, Cote M, Bertrand OF, Poirier P, Clavel MA, Pibarot P, Dumont E (2009) Electrocardiographic changes and clinical outcomes after transapical aortic valve implantation. Am Heart J 158:302–308PubMed

88.

Godin M, Eltchaninoff H, Furuta A, Tron C, Anselme F, Bejar K, Sanchez-Giron C, Bauer F, Litzler PY, Bessou JP, Cribier A (2010) Frequency of conduction disturbances after transcatheter implantation of an Edwards Sapien aortic valve prosthesis. Am J Cardiol 106:707–712PubMed

89.

Piazza N, Onuma Y, Jesserun E, Kint PP, Maugenest AM, Anderson RH, de Jaegere PP, Serruys PW (2008) Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv 1:310–316PubMed

90.

Jilaihawi H, Chin D, Vasa-Nicotera M, Jeilan M, Spyt T, Ng GA, Bence J, Logtens E, Kovac J (2009) Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J 157:860–866PubMed

91.

Erkapic D, Kim WK, Weber M, Mollmann H, Berkowitsch A, Zaltsberg S, Pajitnev DJ, Rixe J, Neumann T, Kuniss M, Sperzel J, Hamm CW, Pitschner HF (2010) Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. Europace 12:1188–1190PubMed

92.

Nuis RJ, Van Mieghem NM, Schultz CJ, Tzikas A, Van der Boon RM, Maugenest AM, Cheng J, Piazza N, van Domburg RT, Serruys PW, de Jaegere PP (2011) Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve System in patients with aortic stenosis. Eur Heart J 32:2067–2074PubMed

93.

Baan J Jr, Yong ZY, Koch KT, Henriques JP, Bouma BJ, Vis MM, Cocchieri R, Piek JJ, de Mol BA (2010) Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis. Am Heart J 159:497–503PubMed

94.

Fraccaro C, Buja G, Tarantini G, Gasparetto V, Leoni L, Razzolini R, Corrado D, Bonato R, Basso C, Thiene G, Gerosa G, Isabella G, Iliceto S, Napodano M (2011) Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol 107:747–754PubMed

95.

Piazza N, Nuis RJ, Tzikas A, Otten A, Onuma Y, Garcia–Garcia H, Schultz C, van Domburg R, van Es GA, van Geuns R, de Jaegere P, Serruys PW (2010) Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation. EuroIntervention 6:475–484PubMed

96.

Grube E, Naber C, Abizaid A, Sousa E, Mendiz O, Lemos P, Kalil Filho R, Mangione J, Buellesfeld L (2011) Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study. JACC Cardiovasc Interv 4:751–757PubMed

97.

John D, Buellesfeld L, Yuecel S, Mueller R, Latsios G, Beucher H, Gerckens U, Grube E (2010) Correlation of Device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding CoreValve prosthesis. JACC Cardiovasc Interv 3:233–243PubMed

98.

Sherif MA, Abdel-Wahab M, Stocker B, Geist V, Richardt D, Tolg R, Richardt G (2010) Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J Am Coll Cardiol 56:1623–1629PubMed

99.

Detaint D, Lepage L, Himbert D, Brochet E, Messika-Zeitoun D, Iung B, Vahanian A (2009) Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. JACC Cardiovasc Interv 2:821–827PubMed

100.

Rodes-Cabau J, Dumont E, Doyle D (2009) “Valve-in-valve” for the treatment of paravalvular leaks following transcatheter aortic valve implantation. Catheter Cardiovasc Interv 74:1116–1119PubMed

101.

Ussia GP, Barbanti M, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Napodano M, Tamburino C (2011) The valve-in-valve technique for treatment of aortic bioprosthesis malposition an analysis of incidence and 1-year clinical outcomes from the italian CoreValve registry. J Am Coll Cardiol 57:1062–1068PubMed

102.

Latib A, Michev I, Laborde JC, Montorfano M, Colombo A (2010) Post-implantation repositioning of the CoreValve percutaneous aortic valve. JACC Cardiovasc Interv 3:119–121PubMed

103.

Stabile E, Sorropago G, Cioppa A, Cota L, Agrusta M, Lucchetti V, Rubino P (2010) Acute left main obstructions following TAVI. EuroIntervention 6:100–105PubMed

104.

Rodes-Cabau J, Gutierrez M, Bagur R, De Larochelliere R, Doyle D, Cote M, Villeneuve J, Bertrand OF, Larose E, Manazzoni J, Pibarot P, Dumont E (2011) Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. J Am Coll Cardiol 57:1988–1999PubMed

105.

Kapadia SR, Svensson L, Tuzcu EM (2009) Successful percutaneous management of left main trunk occlusion during percutaneous aortic valve replacement. Catheter Cardiovasc Interv 73:966–972PubMed

106.

Bagur R, Dumont E, Doyle D, Larose E, Lemieux J, Bergeron S, Bilodeau S, Bertrand OF, De Larochelliere R, Rodes-Cabau J (2010) Coronary ostia stenosis after transcatheter aortic valve implantation. JACC Cardiovasc Interv 3:253–255PubMed

107.

Elhmidi Y, Bleiziffer S, Piazza N, Hutter A, Opitz A, Hettich I, Kornek M, Ruge H, Brockmann G, Mazzitelli D, Lange R (2011) Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation. Am Heart J 161:735–739PubMed

108.

Van Linden A, Kempfert J, Rastan AJ, Holzhey D, Blumenstein J, Schuler G, Mohr FW, Walther T (2011) Risk of acute kidney injury after minimally invasive transapical aortic valve implantation in 270 patients. Eur J Cardiothorac Surg 39:835–842; discussion 842–833PubMed

109.

Bagur R, Webb JG, Nietlispach F, Dumont E, De Larochelliere R, Doyle D, Masson JB, Gutierrez MJ, Clavel MA, Bertrand OF, Pibarot P, Rodes-Cabau J (2010) Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J 31:865–874PubMed

110.

Tamburino C, Barbanti M, Capodanno D, Sarkar K, Cammalleri V, Scarabelli M, Mule M, Imme S, Aruta P, Ussia GP (2012) Early- and mid-term outcomes of transcatheter aortic valve implantation in patients with logistic EuroSCORE less than 20 %: a comparative analysis between different risk strata. Catheter Cardiovasc Interv 79:132–140PubMed

111.

Taylor J (2011) The time has come for a syntax-like trial for transcatheter aortic valve implantation. Eur Heart J 32:128–129PubMed

112.

Webb JG, Wood DA, Ye J, Gurvitch R, Masson JB, Rodes-Cabau J, Osten M, Horlick E, Wendler O, Dumont E, Carere RG, Wijesinghe N, Nietlispach F, Johnson M, Thompson CR, Moss R, Leipsic J, Munt B, Lichtenstein SV, Cheung A (2010) Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation 121:1848–1857PubMed

113.

Pasic M, Unbehaun A, Dreysse S, Buz S, Drews T, Kukucka M, Hetzer R (2011) Transapical aortic valve implantation after previous aortic valve replacement: clinical proof of the “valve-in-valve” concept. J Thorac Cardiovasc Surg 142:270–277PubMed

114.

Kempfert J, Van Linden A, Linke A, Borger MA, Rastan A, Mukherjee C, Ender J, Schuler G, Mohr FW, Walther T (2010) Transapical off-pump valve-in-valve implantation in patients with degenerated aortic xenografts. Ann Thorac Surg 89:1934–1941PubMed

115.

Buellesfeld L, Gerckens U, Grube E (2008) Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis. Catheter Cardiovasc Interv 71:579–584PubMed

116.

Gaia DF, Palma JH, Ferreira CB, Souza JA, Agreli G, Guilhen JC, Telis A, Buffolo E (2010) Transapical aortic valve implantation: results of a Brazilian prosthesis. Rev Bras Cir Cardiovasc 25:293–302PubMed

117.

Gaia DF, Palma JH, Souza JA, Guilhen JC, Telis A, Fischer CH, Ferreira CB, Buffolo E (2009) Off-pump transapical balloon-expandable aortic valve endoprosthesis implantation. Rev Bras Cir Cardiovasc 24:233–238PubMed

118.

Falk V, Schwammenthal EE, Kempfert J, Linke A, Schuler G, Mohr FW, Walther T (2009) New anatomically oriented transapical aortic valve implantation. Ann Thorac Surg 87:925–926PubMed

119.

Falk V, Walther T, Schwammenthal E, Strauch J, Aicher D, Wahlers T, Schafers J, Linke A, Mohr FW (2011) Transapical aortic valve implantation with a self-expanding anatomically oriented valve. Eur Heart J 32:878–887PubMed

120.

Kempfert J, Rastan AJ, Mohr FW, Walther T (2011) A new self-expanding transcatheter aortic valve for transapical implantation - first in man implantation of the JenaValve™. Eur J Cardiothorac Surg 40:761–763PubMed

121.

Rodes-Cabau J (2012) Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol 9:15–29

Title: TAVI 2012: state of the art
Authors: Jochen Reinöhl
Constantin von zur Mühlen
Martin Moser
Stefan Sorg
Christoph Bode
Manfred Zehender
Publication date: 01-05-2013
Publisher: Springer US
Published in: Journal of Thrombosis and Thrombolysis / Issue 4/2013
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-012-0825-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2013

Clinical and prognostic implications of existing and new-onset atrial fibrillation in patients undergoing transcatheter aortic valve implantation

Incidence, predictors, origin and prevention of early and late neurological events after transcatheter aortic valve implantation (TAVI): a comprehensive review of current data

Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies

Access site bleeding after transcatheter aortic valve implantation

Transcatheter aortic valve implantation and bleeding: incidence, predictors and prognosis

Maintaining a minimally invasive approach—vascular closure after trans-catheter aortic valve intervention

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials